Doximity (NYSE:DOCS) Price Target Raised to $30.00

Doximity (NYSE:DOCS) had its price objective hoisted by Barclays from $27.00 to $30.00 in a research note published on Wednesday,Benzinga reports. The firm currently has an equal weight rating on the stock.

Several other research analysts have also weighed in on the stock. Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and set a $18.00 price objective on the stock. in a research note on Monday, August 10th. Piper Sandler reiterated an “overweight” rating and issued a $47.00 target price (up from $42.00) on shares of Doximity in a report on Friday, August 7th. Truist Financial increased their target price on shares of Doximity from $19.00 to $24.00 and gave the stock a “hold” rating in a report on Thursday, August 13th. Royal Bank Of Canada lifted their price target on shares of Doximity from $28.00 to $34.00 and gave the stock an “outperform” rating in a research report on Friday, November 6th. Finally, BMO Capital Markets reissued a “market perform” rating and issued a $30.00 price target on shares of Doximity in a report on Friday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $30.59.

Doximity Trading Up 0.4%

NYSE:DOCS opened at $33.34 on Wednesday. Doximity has a 1-year low of $17.15 and a 1-year high of $51.85. The firm has a market capitalization of $5.95 billion, a price-to-earnings ratio of 43.12, a PEG ratio of 34.59 and a beta of 1.29. The business’s 50-day moving average price is $29.74 and its two-hundred day moving average price is $25.33.

Doximity (NYSE:DOCS) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.17. The company had revenue of $174.54 million during the quarter. Doximity had a return on equity of 15.80% and a net margin of 21.12%. The business’s revenue was up 3.6% compared to the same quarter last year. During the same period last year, the company earned $0.45 earnings per share. Sell-side analysts predict that Doximity will post 0.74 earnings per share for the current year.

Insider Transactions at Doximity

In other news, Director Phoebe Yang sold 1,290 shares of the company’s stock in a transaction dated Wednesday, September 30th. The stock was sold at an average price of $26.71, for a total transaction of $34,455.90. Following the completion of the transaction, the director directly owned 24,744 shares of the company’s stock, valued at $660,912.24. This represents a 4.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 2,613 shares of the stock in a transaction dated Wednesday, October 14th. The stock was sold at an average price of $30.68, for a total value of $80,166.84. Following the transaction, the chief accounting officer owned 101,432 shares of the company’s stock, valued at approximately $3,111,933.76. The trade was a 2.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 22,701 shares of company stock valued at $717,401. 31.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Doximity

Hedge funds have recently made changes to their positions in the business. Marshall Wace LLP bought a new position in shares of Doximity in the third quarter valued at $954,000. Nierenberg Investment Management Company LLC bought a new position in shares of Doximity during the third quarter worth approximately $6,383,000. Bleakley Financial Group LLC acquired a new stake in Doximity during the 3rd quarter worth approximately $351,000. Twin Peaks Wealth Advisors LLC acquired a new stake in Doximity during the 3rd quarter worth approximately $205,000. Finally, First Trust Advisors LP boosted its stake in Doximity by 1,527.1% in the 3rd quarter. First Trust Advisors LP now owns 793,646 shares of the company’s stock valued at $22,492,000 after purchasing an additional 744,870 shares during the period. 87.19% of the stock is owned by institutional investors.

Recent Doximity Headlines

These are some of the DOCS headlines that stood out recently:

• Neutral Sentiment: Investors who bought DOCS shares from August 8, 2024, through May 13, 2026, have until November 16, 2026, to seek appointment as lead plaintiff in the securities class action. The deadline is a procedural step, not a finding of wrongdoing. Rosen Law Firm deadline notice
• Negative Sentiment: The complaint alleges Doximity misled investors or failed to disclose material adverse information during the class period. One notice cites alleged market-share erosion and lower-engagement advertising methods. If proven, the claims could create legal, financial, and reputational risks; they remain allegations. SueWallSt lawsuit notice Glancy Prongay lawsuit notice
• Negative Sentiment: Barclays reportedly set a $30 price target, below the $33.34 share price in the supplied background, indicating a more cautious valuation view. Barclays price target report

Doximity Company Profile

Doximity, Inc. operates a digital platform designed for medical professionals, including physicians and other clinicians. Its services support professional networking, medical news and research discovery, career development, and communication among healthcare professionals. The company also offers clinical workflow tools, including Doximity Dialer, which enables clinicians to make calls and conduct video visits using a work number, as well as digital fax and document services. Doximity provides marketing and recruitment solutions to healthcare organizations and life sciences companies.